Laxminarayan Bhat's Insider Trades & SAST Disclosures
Laxminarayan Bhat's most recent trade in Reviva Pharmaceuticals Holdings Inc. was a trade of 519,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Laxminarayan Bhat.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reviva Pharmaceuticals Hol... | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 519,000 | 519,000 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 181,500 | 181,500 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2024 | 158,451 | 158,451 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2024 | 77,843 | 77,843 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 443,000 | 443,000 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 150,000 | 150,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges